Prognostic value of serum microRNA-122 in hepatocellular carcinoma is dependent on coexisting clinical and laboratory factors

Table 1 Clinical and laboratory characteristics of the patients with hepatocellular carcinoma, n (%)

Characteristics	Value
Patient number	91
Gender
Women	17 (18.7)
Men	74 (81.3)
Age in yr, mean ± SD	67.91 ± 8.98
Etiology
Alcohol abuse	41 (45.1)
Viral hepatitis	12 (13.2)
NASH	13 (14.3)
Hemochromatosis	6 (6.6)
Rare or other cause	19 (20.8)
BCLC stage
0	0 (0.0)
A	16 (17.6)
B	37 (40.6)
C	32 (35.2)
D	6 (6.6)
Child-Pugh score
No liver cirrhosis	16 (17.6)
A	45 (49.4)
B	27 (29.7)
C	3 (3.3)
Treatment
Therapy naive	26 (28.6)
Pretreated	65 (71.4)

NASH: Non-alcoholic steatohepatitis; BCLC: Barcelona clinic liver cancer.